Search

everythinglearnresearchcommunity

for

Search:↓

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Placenta polypeptide injection is a safe and effective treatment for sensitive skin.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Abatacept may help some people with alopecia areata regrow hair.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.